Inogen/$INGN
1D1W1MYTD1Y5YMAX
Capital at risk
About Inogen
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
- Ticker
- $INGN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 753
- Headquarters
- Beverly, United States
- Website
- www.provider.inogen.com
Inogen Metrics
BasicAdvanced
$139M
-
-$0.91
1.60
-
Price and volume
Market cap
$139M
Beta
1.6
52-week high
$9.13
52-week low
$5.20
Average daily volume
248K
Financial strength
Current ratio
2.74
Quick ratio
2.141
Long term debt to equity
7.172
Total debt to equity
9.032
Profitability
EBITDA (TTM)
-9.215
Gross margin (TTM)
44.51%
Net profit margin (TTM)
-6.94%
Operating margin (TTM)
-7.89%
Effective tax rate (TTM)
2.81%
Revenue per employee (TTM)
$470,000
Management effectiveness
Return on assets (TTM)
-6.08%
Return on equity (TTM)
-13.14%
Valuation
Price to revenue (TTM)
0.401
Price to book
0.81
Price to tangible book (TTM)
1.03
Price to free cash flow (TTM)
-14.659
Free cash flow yield (TTM)
-6.82%
Free cash flow per share (TTM)
-0.357
Growth
Revenue change (TTM)
3.15%
Earnings per share change (TTM)
-13.39%
3-year revenue growth (CAGR)
0.48%
10-year revenue growth (CAGR)
7.08%
3-year earnings per share growth (CAGR)
-39.96%
10-year earnings per share growth (CAGR)
1.28%
What the Analysts think about Inogen
Analyst ratings (Buy, Hold, Sell) for Inogen stock.
Analyst projections of the future price of Inogen stock.
Inogen Financial Performance
Revenues and expenses
Inogen Earnings Performance
Company profitability
Upcoming events
No upcoming events
Inogen News
AllArticlesVideos
Funds containing Inogen
Fund name | Fund size | $INGN weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.